Edition:
United States

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

74.15USD
9 Dec 2016
Change (% chg)

$0.63 (+0.86%)
Prev Close
$73.52
Open
$73.82
Day's High
$75.14
Day's Low
$73.71
Volume
114,170
Avg. Vol
113,910
52-wk High
$89.16
52-wk Low
$65.70

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company is engaged in the business of providing the research models required in research and development of new drugs, devices and therapies. The Company operates through three segments: Research Models and Services... (more)

Overall

Beta: 1.10
Market Cap(Mil.): $3,509.42
Shares Outstanding(Mil.): 47.33
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 24.89 41.98 30.40
EPS (TTM): 2.98 -- --
ROI: 7.30 -0.36 15.24
ROE: 18.13 -0.94 16.58

BRIEF-Charles river laboratories Q3 GAAP earnings per share $0.78

Nov 2 Charles River Laboratories International Inc :

Nov 02 2016

BRIEF-Charles River extends integrated discovery program with Genentech

Oct 11 Charles River Laboratories International Inc

Oct 11 2016

BRIEF-Charles River Labs says acquires Agilux Labs for $64 mln

Sept 28 Charles River Laboratories International Inc

Sep 28 2016

BRIEF-Charles River Labs Q2 earnings per share $0.73

Aug 3 Charles River Laboratories International Inc

Aug 03 2016

Earnings vs. Estimates